FIELD: medicine, pharmaceutics.
SUBSTANCE: invention concerns biochemistry and medicine. There is characterised an agent for inactivation of viruses representing derivatives of lysine, glutamic and 6-aminohexanoic acids.
EFFECT: presented agents exhibits ribonuclease, membranolytic and antiviral activities and can be used in medicine as active components for the development of dosage forms used for treating viral diseases.
6 dwg, 4 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT HAVING ANTIVIRAL ACTIVITY | 2008 |
|
RU2402563C2 |
AGENT FOR INACTIVATING DNA VIRUSES | 2012 |
|
RU2480478C1 |
N-SUBSTITUTED 1,4-DIAZABICYCLO-[2,2,2]-OCTANE DERIVATIVES EXHIBITING RNA-ANTIVIRAL ACTIVITY | 2008 |
|
RU2399669C2 |
AGENT SHOWING ANTIVIRAL ACTIVITY ON DNA-VIRUSES | 2012 |
|
RU2487876C1 |
LIPOTETRAPEPTIDES BASED ON DIETHERS OF L-GLUTAMINIC ACID AND METHOD OF OBTAINING THEREOF | 2013 |
|
RU2533554C1 |
PEPTIDE-LIKE COMPOUND SHOWING ANTIVIRAL ACTIVITY, AND METHOD FOR PREPARING IT | 2010 |
|
RU2450806C2 |
LIPOTRIPEPTIDES BASED ON DIESTERS OF L-GLUTAMINIC ACID AND METHOD OF THEIR OBTAINING | 2014 |
|
RU2575851C1 |
CONJUGATE ANTIBODY-DERIVATIVE OF PYRROLOBENZODIAZEPINE | 2018 |
|
RU2820928C2 |
CATIONIC DIMERIC AMPHIPHILES AS AGENTS FOR TRANSFECTION AND METHOD FOR THEIR PREPARING | 2002 |
|
RU2233834C2 |
INSULIN DERIVATIVES | 2004 |
|
RU2352581C2 |
Authors
Dates
2010-09-20—Published
2008-12-17—Filed